← Eichor
Study identifier: NCT06772831 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cognitive Reappraisal Training for Borderline Personality (BPD)

Condition: Borderline Personality Disorder  ·  Sponsor: Icahn School of Medicine at Mount Sinai

PhaseNA
Planned participants130
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

Previous work by the group convinced the researchers to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in concert with evidence-based treatments of BPD. The present proposal aims to refine and test a proposed clinical intervention for BPD patients, training in reappraisal-by-distancing, in terms of its ability to influence hypothesized neural and behavioral targets and, once that is established, to demonstrate its ability improve clinically relevant outcome measures.

This description comes directly from the study's public registry record.

Talk to the study team

Harold W Koenigsberg, MD  ·  718-584-9000  ·  harold.koenigsberg@mssm.edu

Brian B Kang, BA  ·  212-241-9775  ·  brian.kang@mssm.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Icahn School of Medicine at Mount SinaiNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06772831